• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Influence of age on tobramycin pharmacokinetics in patients with normal renal function.年龄对肾功能正常患者妥布霉素药代动力学的影响。
Antimicrob Agents Chemother. 1981 Nov;20(5):587-9. doi: 10.1128/AAC.20.5.587.
2
Influence of age on amikacin pharmacokinetics in patients without renal disease. Comparison with gentamicin and tobramycin.
Eur J Clin Pharmacol. 1983;24(5):639-42. doi: 10.1007/BF00542214.
3
Tobramycin sulfate elimination in premature infants.
J Pediatr. 1983 Jul;103(1):131-5. doi: 10.1016/s0022-3476(83)80799-9.
4
Systematically individualizing tobramycin dosage regimens.
J Clin Pharmacol. 1980 Oct;20(10):570-80. doi: 10.1002/j.1552-4604.1980.tb01672.x.
5
Gentamicin and tobramycin pharmacokinetics in patients with cystic fibrosis.
Clin Pharm. 1983 May-Jun;2(3):262-4.
6
Clinical pharmacology of tobramycin in children.
J Infect Dis. 1978 May;137(5):592-6. doi: 10.1093/infdis/137.5.592.
7
Pharmacokinetics of intravenously administered tobramycin in normal volunteers and in renal-impaired and hemodialyzed patients.静脉注射妥布霉素在正常志愿者、肾功能受损患者及血液透析患者中的药代动力学。
J Infect Dis. 1976 Aug;134 Suppl:S118-24. doi: 10.1093/infdis/134.supplement_1.s118.
8
Tobramycin kinetics in newborn infants.
J Pediatr. 1983 Jul;103(1):136-8. doi: 10.1016/s0022-3476(83)80800-2.
9
[Pharmacokinetics of tobramycin (Brulamycin) in young and old age].[妥布霉素(布鲁拉霉素)在青年和老年人群中的药代动力学]
Orv Hetil. 1982 Sep 19;123(38):2357-9.
10
Gentamicin pharmacokinetics: effect of aging in patients with normal renal function.
J Am Geriatr Soc. 1982 May;30(5):309-11. doi: 10.1111/j.1532-5415.1982.tb05618.x.

引用本文的文献

1
Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations.老年患者中氨基糖苷类药物的使用。药代动力学及临床考量。
Drugs Aging. 1997 Apr;10(4):259-77. doi: 10.2165/00002512-199710040-00003.
2
Influence of age on amikacin pharmacokinetics in patients without renal disease. Comparison with gentamicin and tobramycin.
Eur J Clin Pharmacol. 1983;24(5):639-42. doi: 10.1007/BF00542214.
3
Pharmacokinetics of tobramycin and gentamicin in abusers of intravenous drugs.妥布霉素和庆大霉素在静脉注射毒品滥用者中的药代动力学。
Antimicrob Agents Chemother. 1985 Mar;27(3):285-90. doi: 10.1128/AAC.27.3.285.
4
Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance.囊性纤维化患者的抗生素药代动力学。差异及临床意义。
Clin Pharmacokinet. 1987 Oct;13(4):228-53. doi: 10.2165/00003088-198713040-00002.
5
Clinical pharmacokinetics of antibiotics in patients with impaired renal function.肾功能受损患者抗生素的临床药代动力学
Clin Pharmacokinet. 1992 Mar;22(3):169-210. doi: 10.2165/00003088-199222030-00002.

本文引用的文献

1
Rapid gentamicin elimination in obstetric patients.
Obstet Gynecol. 1980 Nov;56(5):559-64.
2
Gentamicin dosage requirements: wide interpatient variations in 242 surgery patients with normal renal function.庆大霉素剂量需求:242例肾功能正常的手术患者之间存在广泛的个体差异。
Surgery. 1980 Feb;87(2):164-9.
3
Increased gentamicin dosage requirements: rapid elimination in 249 gynecology patients.
Am J Obstet Gynecol. 1981 Apr 15;139(8):896-900. doi: 10.1016/0002-9378(81)90954-6.
4
Correlation of serum creatinine concentration and gentamicin half-life.血清肌酐浓度与庆大霉素半衰期的相关性。
JAMA. 1972 Feb 21;219(8):1037-41.
5
Gentamicin blood levels: a guide to nephrotoxicity.庆大霉素血药浓度:肾毒性的一项指标
Antimicrob Agents Chemother. 1975 Jul;8(1):58-62. doi: 10.1128/AAC.8.1.58.
6
Gentamicin sulfate pharmacokinetics: lower levels of gentamicin in blood during fever.
J Infect Dis. 1975 Sep;132(3):270-5. doi: 10.1093/infdis/132.3.270.
7
Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients.采用多次静脉输注给药方案的药代动力学:烧伤患者中的庆大霉素。
J Pharmacokinet Biopharm. 1976 Apr;4(2):183-95. doi: 10.1007/BF01086153.
8
Inactivation of gentamicin by penicillins in patients with renal failure.肾衰竭患者中青霉素对庆大霉素的灭活作用。
Antimicrob Agents Chemother. 1976 Jun;9(6):1004-11. doi: 10.1128/AAC.9.6.1004.
9
Kinetic model for gentamicin dosing with the use of individual patient parameters.使用个体患者参数的庆大霉素给药动力学模型。
Clin Pharmacol Ther. 1977 Mar;21(3):362-9. doi: 10.1002/cpt1977213362.
10
Predictability of blood levels of gentamicin in man.庆大霉素在人体中的血药浓度可预测性。
J Infect Dis. 1975 Aug;132(2):165-74. doi: 10.1093/infdis/132.2.165.

年龄对肾功能正常患者妥布霉素药代动力学的影响。

Influence of age on tobramycin pharmacokinetics in patients with normal renal function.

作者信息

Bauer L A, Blouin R A

出版信息

Antimicrob Agents Chemother. 1981 Nov;20(5):587-9. doi: 10.1128/AAC.20.5.587.

DOI:10.1128/AAC.20.5.587
PMID:7325627
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC181756/
Abstract

The influence of age on tobramycin half-life, volume of distribution, and clearance was examined in 77 patients with infections due to gram-negative bacteria. All patients had normal renal function and hematocrits, were within 20% of their ideal body weight, did not receive penicillin antibiotics concurrently, and had a fever. Twenty-five patients were between 20 and 39 years of age, 23 patients were 40 to 59 years old, and 29 patients were in the age group 60 to 79 years. The mean half-lives were 2.3, 2.2, and 2.4 h, respectively, for the three age groupings. The average clearance and volume of distribution terms were, respectively, 1.34 ml/min per kg and 0.25 liter/kg for the younger group, 1.44 ml/min per kg and 0.26 liter/kg for the middle age group, and 1.25 ml/min per kg and 0.25 liter/kg for the older group. There was no significant difference among the three groups for any of the parameters (P less than 0.05, analysis of variance). Correlation coefficients determined from individual plots of the three pharmacokinetic parameters versus age revealed no correlation between any parameter and age. Forty-five percent of the patients required doses greater than the recommended maximum (5 mg/kg per day) to achieve desired steady-state concentrations. Since tobramycin pharmacokinetics do not change as age increased, doses do not need to be arbitrarily changed in older patients with normal renal function.

摘要

在77例革兰氏阴性菌感染患者中,研究了年龄对妥布霉素半衰期、分布容积和清除率的影响。所有患者肾功能和血细胞比容均正常,体重在理想体重的20%以内,未同时接受青霉素类抗生素治疗,且均有发热症状。25例患者年龄在20至39岁之间,23例患者年龄为40至59岁,29例患者年龄在60至79岁之间。三个年龄组的平均半衰期分别为2.3小时、2.2小时和2.4小时。年轻组的平均清除率和分布容积分别为每千克体重1.34毫升/分钟和0.25升/千克,中年组为每千克体重1.44毫升/分钟和0.26升/千克,老年组为每千克体重1.25毫升/分钟和0.25升/千克。三组之间的任何参数均无显著差异(方差分析,P<0.05)。根据三个药代动力学参数与年龄的个体图确定的相关系数显示,任何参数与年龄之间均无相关性。45%的患者需要高于推荐最大剂量(5毫克/千克/天)才能达到所需的稳态浓度。由于妥布霉素的药代动力学不会随着年龄的增加而改变,因此肾功能正常的老年患者无需随意调整剂量。